Biotage Sells Its Biosystems Unit Sweden’s Biotage has sold its Biosystems division to Qiagen, in the Netherlands, for $53 million. The purchase includes a 17.5% stake in Corbett Life Science, the Australian parent of four biotech operations that make and sell life sciences instrumentation. Biotage’s Biosystems division had sales of about $14 million in 2007, centered on its Pyrosequencing technology and the PyroMark real-time sequencing detection system. Qiagen intends to offer jobs to all Biosystems employees. Meanwhile, Biotage will focus on its discovery chemistry business, which offers purification, analysis, and reaction-screening systems. Companies, Governments Tackle Melamine Analysis In the wake of the recent melamine scare in China, three companies are independently developing new methods to detect the compound in dairy products.
by Celia H. Arnaud and Ann M. Thayer |
October 27, 2008